
Ayaz R. Sheikh
Supervisory Patent Examiner (ID: 10143, Phone: (571)272-3795 , Office: P/2476 )
| Most Active Art Unit | 2305 |
| Art Unit(s) | 2308, 2131, 2781, 2787, 2476, 2155, 2305, 2899 |
| Total Applications | 441 |
| Issued Applications | 294 |
| Pending Applications | 28 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14627379
[patent_doc_number] => 20190227057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => MOLECULAR SENSORS
[patent_app_type] => utility
[patent_app_number] => 16/331327
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331327 | Molecular sensors | Sep 7, 2017 | Issued |
Array
(
[id] => 15165647
[patent_doc_number] => 10488308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Preparation of lipemic plasma or serum samples for the determination of a lipid interference
[patent_app_type] => utility
[patent_app_number] => 15/698618
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5298
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698618
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698618 | Preparation of lipemic plasma or serum samples for the determination of a lipid interference | Sep 6, 2017 | Issued |
Array
(
[id] => 12794959
[patent_doc_number] => 20180156822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => BIOMARKER FOR CARDIAC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/698554
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698554 | BIOMARKER FOR CARDIAC DISORDERS | Sep 6, 2017 | Abandoned |
Array
(
[id] => 13703427
[patent_doc_number] => 20170362668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => CO-BINDER ASSISTED ASSAY METHODS
[patent_app_type] => utility
[patent_app_number] => 15/696953
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15696953
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/696953 | Co-binder assisted assay methods | Sep 5, 2017 | Issued |
Array
(
[id] => 12680905
[patent_doc_number] => 20180118801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/695812
[patent_app_country] => US
[patent_app_date] => 2017-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695812
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/695812 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES | Sep 4, 2017 | Abandoned |
Array
(
[id] => 12329592
[patent_doc_number] => 09945854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies
[patent_app_type] => utility
[patent_app_number] => 15/693679
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10265
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/693679 | Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies | Aug 31, 2017 | Issued |
Array
(
[id] => 13705387
[patent_doc_number] => 20170363648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => Biosensors Engineered from Conditionally Stable Ligand-Binding Domains
[patent_app_type] => utility
[patent_app_number] => 15/692211
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/692211 | Biosensors Engineered from Conditionally Stable Ligand-Binding Domains | Aug 30, 2017 | Abandoned |
Array
(
[id] => 14870813
[patent_doc_number] => 20190285648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER
[patent_app_type] => utility
[patent_app_number] => 16/328846
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328846 | NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER | Aug 29, 2017 | Abandoned |
Array
(
[id] => 13691903
[patent_doc_number] => 20170356906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT
[patent_app_type] => utility
[patent_app_number] => 15/685206
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/685206 | NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT | Aug 23, 2017 | Abandoned |
Array
(
[id] => 17681876
[patent_doc_number] => 11366124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
[patent_app_type] => utility
[patent_app_number] => 16/326737
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 4
[patent_no_of_words] => 10769
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326737
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326737 | Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers | Aug 22, 2017 | Issued |
Array
(
[id] => 14504473
[patent_doc_number] => 20190195891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/325393
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325393 | DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES | Aug 17, 2017 | Abandoned |
Array
(
[id] => 18316028
[patent_doc_number] => 11630103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Product and methods useful for modulating and evaluating immune responses
[patent_app_type] => utility
[patent_app_number] => 16/325807
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 59
[patent_no_of_words] => 153327
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325807 | Product and methods useful for modulating and evaluating immune responses | Aug 16, 2017 | Issued |
Array
(
[id] => 13719935
[patent_doc_number] => 20170370922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => FLUIDIC DEVICE, SYSTEM, AND METHOD
[patent_app_type] => utility
[patent_app_number] => 15/679816
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679816 | Fluidic device, system, and method | Aug 16, 2017 | Issued |
Array
(
[id] => 12157345
[patent_doc_number] => 20180028610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'METHODS FOR DETECTING CARDIAC DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 15/674053
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11163
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674053 | Methods for detecting cardiac damage | Aug 9, 2017 | Issued |
Array
(
[id] => 14467879
[patent_doc_number] => 20190185582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => DETERMINATION OF NON-HUMAN MAMMAL TK1 PROTEIN LEVELS
[patent_app_type] => utility
[patent_app_number] => 16/323224
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323224 | DETERMINATION OF NON-HUMAN MAMMAL TK1 PROTEIN LEVELS | Aug 8, 2017 | Abandoned |
Array
(
[id] => 14442049
[patent_doc_number] => 20190178897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => HISTONES AND/OR PROADM AS MARKERS INDICATING ORGAN DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/324023
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324023 | HISTONES AND/OR PROADM AS MARKERS INDICATING ORGAN DYSFUNCTION | Aug 7, 2017 | Abandoned |
Array
(
[id] => 12126253
[patent_doc_number] => 20180009840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'ENHANCED FUNCTIONALITY AND DELIVERY OF A PROTEIN FROM A POROUS SUBSTRATE'
[patent_app_type] => utility
[patent_app_number] => 15/667478
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14809
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667478 | Enhanced functionality and delivery of a protein from a porous substrate | Aug 1, 2017 | Issued |
Array
(
[id] => 12627096
[patent_doc_number] => 20180100862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => Highly Sensitive System and Methods for Analysis of Troponin
[patent_app_type] => utility
[patent_app_number] => 15/660783
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660783 | Highly Sensitive System and Methods for Analysis of Troponin | Jul 25, 2017 | Abandoned |
Array
(
[id] => 16384438
[patent_doc_number] => 10809266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Quantitative massively parallel proteomics
[patent_app_type] => utility
[patent_app_number] => 15/656423
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 11137
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15656423
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/656423 | Quantitative massively parallel proteomics | Jul 20, 2017 | Issued |
Array
(
[id] => 14467775
[patent_doc_number] => 20190185530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => COMPLEX-SPECIFIC STANDARDIZATION OF IMMUNOLOGICAL METHODS FOR THE QUANTIFICATION OF S100A12
[patent_app_type] => utility
[patent_app_number] => 16/318854
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318854 | Complex-specific standardization of immunological methods for the quantification of S100A12 | Jul 17, 2017 | Issued |